Death waits for no man - Does it wait for a virus? How enteroviruses induce and control cell death

Cytokine and Growth Factor Reviews

Volumn 25, Issue 5, 2014, Pages 587-596

  Harris, Katharine G ^a   Coyne, Carolyn B ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cell death; Coxsackievirus; Enterovirus; Poliovirus

Indexed keywords

APOPTOSIS; ARTICLE; CELL DEATH; ENTEROVIRUS INFECTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PERSISTENT VIRUS INFECTION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRAL TROPISM; VIRUS CELL INTERACTION; VIRUS ENCEPHALITIS; VIRUS MENINGITIS; VIRUS MYOCARDITIS; VIRUS REPLICATION; VIRUS TRANSMISSION; ANIMAL; ENTEROVIRUS; PATHOPHYSIOLOGY; PHYSIOLOGY; VIROLOGY;

ANIMALS; APOPTOSIS; CELL DEATH; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; HUMANS; SIGNAL TRANSDUCTION;

EID: 84908275808     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2014.08.002     Document Type: Article

References (129)

1. Centers for Disease Control Non-Polio enterovirus infections 2011.
2. International Committee on Taxonomy of Viruses Virus taxonomy: 2012 release (current) 2012.
3. Huang C., Morse D., Slater B., Anand M., Tobin E., Smith P., et al. Multiple-year experience in the diagnosis of viral central nervous system infections with a panel of polymerase chain reaction assays for detection of 11 viruses. Clin Infect Dis 2004, 39:630-635.
4. Koskiniemi M., Rantalaiho T., Piiparinen H., von Bonsdorff C.H., Farkkila M., Jarvinen A., et al. Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J Neurovirol 2001, 7:400-408.
5. Xu Y., Zhaori G., Vene S., Shen K., Zhou Y., Magnius L.O., et al. Viral etiology of acute childhood encephalitis in Beijing diagnosed by analysis of single samples. Pediatr Infect Dis J 1996, 15:1018-1024.
6. Fowlkes A.L., Honarmand S., Glaser C., Yagi S., Schnurr D., Oberste M.S., et al. Enterovirus-associated encephalitis in the California encephalitis project, 1998-2005. J Infect Dis 2008, 198:1685-1691.
7. Khetsuriani N., Fowlkes A.L., Oberste M.S., Pallansch M.A. Enterovirus Surveillance - United States, 1970-2005. MMWR 2006, 55:1-20. Centers for Disease Control.
8. Upton J.W., Chan F.K. Staying alive: cell death in antiviral immunity. Mol Cell 2014, 54:273-280.
9. Bissel S.J., Winkler C.C., Deltondo J., Wang G., Williams K., Wiley C.A. Coxsackievirus B4 myocarditis and meningoencephalitis in newborn twins. Neuropathology 2014.
10. Racaniello V.R. One hundred years of poliovirus pathogenesis. Virology 2006, 344:9-16.
11. Rose N.R., Kaya Z. Myocarditis and dilated cardiomyopathy. The autoimmune diseases 2014, 1033-1048. 5th ed.
12. Andreoletti L., Leveque N., Boulagnon C., Brasselet C., Fornes P. Viral causes of human myocarditis. Arch Cardiovasc Dis 2009, 102:559-568.
13. Tam P.E. Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease. Viral Immunol 2006, 19:133-146.
14. Martino T., Liu P., Petric M., Sole M. Enteroviral myocarditis and dilated cardiomyopathy: a review of clinical and experimental studies. Human enterovirus infections 1995, 291-351. American Society for Microbiology, Washington, DC. H. Rotbart (Ed.).
15. Herzum M., Ruppert V., Kuytz B., Jomaa H., Nakamura I., Maisch B. Coxsackievirus B3 infection leads to cell death of cardiac myocytes. J Mol Cell Cardiol 1994, 26:907-913.
16. Ahn J., Joo C.H., Seo I., Kim D., Kim Y.K., Lee H. All CVB serotypes and clinical isolates induce irreversible cytopathic effects in primary cardiomyocytes. J Med Virol 2005, 75:290-294.
17. Claycomb W.C., Lanson N.A., Stallworth B.S., Egeland D.B., Delcarpio J.B., Bahinski A., et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 1998, 95:2979-2984.
18. Miteva K., Haag M., Peng J., Savvatis K., Becher P.M., Seifert M., et al. Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis. PLoS ONE 2011, 6:e28513.
19. Joo C.H., Hong H.N., Kim E.O., Im J.O., Yoon S.Y., Ye J.S., et al. Coxsackievirus B3 induces apoptosis in the early phase of murine myocarditis: a comparative analysis of cardiovirulent and noncardiovirulent strains. Intervirology 2003, 46:135-140.
20. Kyto V., Lapatto R., Lakkisto P., Saraste A., Voipio-Pulkki L.M., Vuorinen T., et al. Glutathione depletion and cardiomyocyte apoptosis in viral myocarditis. Eur J Clin Invest 2004, 34:167-175.
21. Venteo L., Bourlet T., Renois F., Douche-Aourik F., Mosnier J.F., Maison G.L., et al. Enterovirus-related activation of the cardiomyocyte mitochondrial apoptotic pathway in patients with acute myocarditis. Eur Heart J 2010, 31:728-736.
22. Chow L.H., Beisel K.W., McManus B.M. Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab Invest 1992, 66:24-31.
23. Wolfgram L.J., Beisel K.W., Rose N.R. Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis. J Exp Med 1985, 161:1112-1121.
24. Maisch B., Berg P.A., Kochsiek K. Autoantibodies and serum inhibition factors (SIF) in patients with myocarditis. Klin Wochenschr 1980, 58:219-225.
25. Craig M.E., Nair S., Stein H., Rawlinson W.D. Viruses and type I diabetes: a new look at an old story. Pediatr Diabetes 2013, 14:149-158.
26. Yeung W.C., Rawlinson W.D., Craig M.E. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 2011, 342:d35.
27. Richardson S.J., Willcox A., Bone A.J., Foulis A.K., Morgan N.G. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 2009, 52:1143-1151.
28. Yoon J.W., Austin M., Onodera T., Notkins A.L. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979, 300:1173-1179.
29. Hanafusa T., Imagawa A. Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat Clin Pract Endocrinol Metab 2007, 3:36-45. [quiz 32p following 69].
30. Imagawa A., Hanafusa T., Makino H., Miyagawa J.I., Juto P. High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes. Diabetologia 2005, 48:290-293.
31. Colli M.L., Nogueira T.C., Allagnat F., Cunha D.A., Gurzov E.N., Cardozo A.K., et al. Exposure to the viral by-product dsRNA or coxsackivirus B5 triggers pancreatic beta cel apoptosis via a Bim/Mcl-1 imbalance. PLoS Pathog 2011, 7.
32. Roivainen M., Ylipaasto P., Savolainen C., Galama J., Hovi T., Otonkoski T. Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Diabetologia 2002, 45:693-702.
33. Tanaka S., Nishida Y., Aida K., Maruyama T., Shimada A., Suzuki M., et al. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes. Diabetes 2009, 58:2285-2291.
34. Dotta F., Censini S., van Halteren A.G., Marselli L., Masini M., Dionisi S., et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci USA 2007, 104:5115-5120.
35. Vreugdenhil G.R., Geluk A., Ottenhoff T.H., Melchers W.J., Roep B.O., Galama J.M. Molecular mimicry in diabetes mellitus: the homologous domain in coxsackie B virus protein 2C and islet autoantigen GAD65 is highly conserved in the coxsackie B-like enteroviruses and binds to the diabetes associated HLA-DR3 molecule. Diabetologia 1998, 41:40-46.
36. Bason C., Lorini R., Lunardi C., Dolcino M., Giannattasio A., d'Annunzio G., et al. In type 1 diabetes a subset of anti-coxsackievirus B4 antibodies recognize autoantigens and induce apoptosis of pancreatic beta cells. PLOS ONE 2013, 8:e57729.
37. Horwitz M.S., Bradley L.M., Harbertson J., Krahl T., Lee J., Sarvetnick N. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 1998, 4:781-785.
38. World Health Organization Poliomyelitis fact sheet number 114 2014.
39. Modlin J.F. Poliomyelitis and poliovirus immunization. Human enterovirus infections 1995, 195-220. American Society for Microbiology, Washington, D.C. H. Rotbart (Ed.).
40. Mueller S., Wimmer E., Cello J. Poliovirus and poliomyelitis: a tale of guts, brains, and an accidental event. Virus Res 2005, 111:175-193.
41. Girard S., Couderc T., Destombes J., Thiesson D., Delpeyroux F., Blondel B. Poliovirus induces apoptosis in the mouse central nervous system. J Virol 1999, 73:6066-6072.
42. Autret A., Martin-Latil S., Mousson L., Wirotius A., Petit F., Arnoult D., et al. Poliovirus induces Bax-dependent cell death mediated by c-Jun NH2-terminal kinase. J Virol 2007, 81:7504-7516.
43. Rotbart H. Meningitis and encephalitis. Human enterovirus infections 1995, 271-289. American Society for Microbiology, Washington, D.C. H. Rotbart (Ed.).
44. Yip C.C., Lau S.K., Woo P.C., Yuen K.Y. Human enterovirus 71 epidemics: what's next?. Emerg Health Threats J 2013, 6:19780.
45. Wong K.T., Munisamy B., Ong K.C., Kojima H., Noriyo N., Chua K.B., et al. The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J Neuropathol Exp Neurol 2008, 67:162-169.
46. Wong K.T., Ng K.Y., Ong K.C., Ng W.F., Shankar S.K., Mahadevan A., et al. Enterovirus 71 encephalomyelitis and Japanese encephalitis can be distinguished by topographic distribution of inflammation and specific intraneuronal detection of viral antigen and RNA. Neuropathol Appl Neurobiol 2012, 38:443-453.
47. Chen T.C., Lai Y.K., Yu C.K., Juang J.L. Enterovirus 71 triggering of neuronal apoptosis through activation of Abl-Cdk5 signalling. Cell Microbiol 2007, 9:2676-2688.
48. Chang S.C., Lin J.Y., Lo L.Y., Li M.L., Shih S.R. Diverse apoptotic pathways in enterovirus 71-infected cells. J Neurovirol 2004, 10:338-349.
49. Fujii K., Nagata N., Sato Y., Ong K.C., Wong K.T., Yamayoshi S., et al. Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc Natl Acad Sci USA 2013, 110:14753-14758.
50. Centers for Disease Control Increased detection and severe neonatal disease associated with Coxsackievirus B1 infection - United States, 2007 2008.
51. Feuer R., Mena I., Pagarigan R.R., Harkins S., Hassett D.E., Whitton J.L. Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Am J Pathol 2003, 163:1379-1393.
52. Ruller C.M., Tabor-Godwin J.M., Van Deren D.A., Robinson S.M., Maciejewski S., Gluhm S., et al. Neural stem cell depletion and CNS developmental defects after enteroviral infection. Am J Pathol 2012, 180:1107-1120.
53. Ozoren N., El-Deiry W.S. Cell surface death receptor signaling in normal and cancer cells. Semin Cancer Biol 2003, 13:135-147.
54. Zhao X., Ai M., Guo Y., Zhou X., Wang L., Li X., et al. Poly I:C-induced tumor cell apoptosis mediated by pattern-recognition receptors. Cancer Biother Radiopharm 2012, 27:530-534.
55. Roos W.P., Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol Med 2006, 12:440-450.
56. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972, 26:239-257.
57. Yuan J., Shaham S., Ledoux S., Ellis H.M., Horvitz H.R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 1993, 75:641-652.
58. Salvesen G.S., Dixit V.M. Caspases: intracellular signaling by proteolysis. Cell 1997, 91:443-446.
59. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007, 35:495-516.
60. Murphy J.M., Silke J. Ars Moriendi; the art of dying well - new insights into the molecular pathways of necroptotic cell death. EMBO Rep 2014, 15:155-164.
61. Carthy C.M., Yanagawa B., Luo H., Granville D.J., Yang D., Cheung P., et al. Bcl-2 and Bcl-xL overexpression inhibits cytochrome c release, activation of multiple caspases, and virus release following coxsackievirus B3 infection. Virology 2003, 313:147-157.
62. Carthy C.M., Granville D.J., Watson K.A., Anderson D.R., Wilson J.E., Yang D., et al. Caspase activation and specific cleavage of substrates after coxsackievirus B3-induced cytopathic effect in HeLa cells. J Virol 1998, 72:7669-7675.
63. Gomes R., Guerra-Sa R., Arruda E. Coxsackievirus B5 induced apoptosis of HeLa cells: effects on p53 and SUMO. Virology 2010, 396:256-263.
64. Agol V.I., Belov G.A., Bienz K., Egger D., Kolesnikova M.S., Raikhlin N.T., et al. Two types of death of poliovirus-infected cells: caspase involvement in the apoptosis but not cytopathic effect. Virology 1998, 252:343-353.
65. Brisac C., Teoule F., Autret A., Pelletier I., Colbere-Garapin F., Brenner C., et al. Calcium flux between the endoplasmic reticulum and mitochondrion contributes to poliovirus-induced apoptosis. J Virol 2010, 84:12226-12235.
66. Autret A., Martin-Latil S., Brisac C., Mousson L., Colbere-Garapin F., Blondel B. Early phosphatidylinositol 3-kinase/Akt pathway activation limits poliovirus-induced JNK-mediated cell death. J Virol 2008, 82:3796-3802.
67. Kuo R.L., Kung S.H., Hsu Y.Y., Liu W.T. Infection with enterovirus 71 or expression of its 2A protease induces apoptotic cell death. J Gen Virol 2002, 83:1367-1376.
68. Lu J.R., Lu W.W., Lai J.Z., Tsai F.L., Wu S.H., Lin C.W., et al. Calcium flux and calpain-mediated activation of the apoptosis-inducing factor contribute to enterovirus 71-induced apoptosis. J Gen Virol 2013, 94:1477-1485.
69. Croall D.E., Ersfeld K. The calpains: modular designs and functional diversity. Genome Biol 2007, 8:218.
70. 2+ transfer in the control of apoptosis. Oncogene 2008, 27:6407-6418.
71. van Kuppeveld F.J., Hoenderop J.G., Smeets R.L., Willems P.H., Dijkman H.B., Galama J.M., et al. Coxsackievirus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release. EMBO J 1997, 16:3519-3532.
72. van Kuppeveld F.J., de Jong A.S., Melchers W.J., Willems P.H. Enterovirus protein 2B po(u)res out the calcium: a viral strategy to survive?. Trends Microbiol 2005, 13:41-44.
73. Ron D., Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007, 8:519-529.
74. Kim R., Emi M., Tanabe K., Murakami S. Role of the unfolded protein response in cell death. Apoptosis 2006, 11:5-13.
75. Zhang H.M., Ye X., Su Y., Yuan J., Liu Z., Stein D.A., et al. Coxsackievirus B3 infection activates the unfolded protein response and induces apoptosis through downregulation of p58IPK and activation of CHOP and SREBP1. J Virol 2010, 84:8446-8459.
76. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B.A., et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 2000, 403:98-103.
77. Oyadomari S., Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 2004, 11:381-389.
78. Herr I., Wilhelm D., Meyer E., Jeremias I., Angel P., Debatin K.M. JNK/SAPK activity contributes to TRAIL-induced apoptosis. Cell Death Differ 1999, 6:130-135.
79. Paul A., Wilson S., Belham C.M., Robinson C.J., Scott P.H., Gould G.W., et al. Stress-activated protein kinases: activation, regulation and function. Cell Signal 1997, 9:403-410.
80. Kim S.M., Park J.H., Chung S.K., Kim J.Y., Hwang H.Y., Chung K.C., et al. Coxsackievirus B3 infection induces cyr61 activation via JNK to mediate cell death. J Virol 2004, 78:13479-13488.
81. Si X., Luo H., Morgan A., Zhang J., Wong J., Yuan J., et al. Stress-activated protein kinases are involved in coxsackievirus B3 viral progeny release. J Virol 2005, 79:13875-13881.
82. Jensen K.J., Garmaroudi F.S., Zhang J., Lin J., Boroomand S., Zhang M., et al. An ERK-p38 subnetwork coordinates host cell apoptosis and necrosis during coxsackievirus B3 infection. Cell Host Microbe 2013, 13:67-76.
83. Hellen C., Wimmer E. Enterovirus structure and assembly. Human enterovirus infections 1995, 155-174. American Society for Microbiology, Washington, D.C. H. Rotbart (Ed.).
84. Haller A., Semler B. Translation and host cell shutoff. Human enterovirus infections 1995, 113-133. American Society for Microbiology, Washington, DC. H. Rotbart (Ed.).
85. Schlegel A., Kirkegaard K. Cell biology of enterovirus infection. Human enterovirus infections 1995, 135-154. American Society for Microbiology, Washington, DC. H. Rotbart (Ed.).
86. Chau D.H., Yuan J., Zhang H., Cheung P., Lim T., Liu Z., et al. Coxsackievirus B3 proteases 2A and 3C induce apoptotic cell death through mitochondrial injury and cleavage of eIF4GI but not DAP5/p97/NAT1. Apoptosis 2007, 12:513-524.
87. Calandria C., Irurzun A., Barco A., Carrasco L. Individual expression of poliovirus 2Apro and 3Cpro induces activation of caspase-3 and PARP cleavage in HeLa cells. Virus Res 2004, 104:39-49.
88. Barco A., Feduchi E., Carrasco L. Poliovirus protease 3C(pro) kills cells by apoptosis. Virology 2000, 266:352-360.
89. Li M.L., Hsu T.A., Chen T.C., Chang S.C., Lee J.C., Chen C.C., et al. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology 2002, 293:386-395.
90. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
91. Cordell-Stewart B., Taylor M.W. Effect of viral double-stranded RNA on mammalian cells in culture: cytotoxicity under conditions preventing viral replication and protein synthesis. J Virol 1973, 12:360-366.
92. Harris K.G., Coyne C.B. Enter at your own risk: how enteroviruses navigate the dangerous world of pattern recognition receptor signaling. Cytokine 2013, 63:230-236.
93. Ylipaasto P., Kutlu B., Rasilainen S., Rasschaert J., Salmela K., Teerijoki H., et al. Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets. Diabetologia 2005, 48:1510-1522.
94. Castelli J.C., Hassel B.A., Wood K.A., Li X.L., Amemiya K., Dalakas M.C., et al. A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system. J Exp Med 1997, 186:967-972.
95. Li G., Xiang Y., Sabapathy K., Silverman R.H. An apoptotic signaling pathway in the interferon antiviral response mediated by RNase L and c-Jun NH2-terminal kinase. J Biol Chem 2004, 279:1123-1131.
96. Henke A., Nestler M., Strunze S., Saluz H.P., Hortschansky P., Menzel B., et al. The apoptotic capability of coxsackievirus B3 is influenced by the efficient interaction between the capsid protein VP2 and the proapoptotic host protein Siva. Virology 2001, 289:15-22.
97. Henke A., Launhardt H., Klement K., Stelzner A., Zell R., Munder T. Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein siva. J Virol 2000, 74:4284-4290.
98. Chu F., Borthakur A., Sun X., Barkinge J., Gudi R., Hawkins S., et al. The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis. Apoptosis 2004, 9:83-95.
99. Gullberg M., Tolf C., Jonsson N., Polacek C., Precechtelova J., Badurova M., et al. A single coxsackievirus B2 capsid residue controls cytolysis and apoptosis in rhabdomyosarcoma cells. J Virol 2010, 84:5868-5879.
100. Bozym R.A., Patel K., White C., Cheung K.H., Bergelson J.M., Morosky S.A., et al. Calcium signals and calpain-dependent necrosis are essential for release of coxsackievirus B from polarized intestinal epithelial cells. Mol Biol Cell 2011, 22:3010-3021.
101. Rasilainen S., Ylipaasto P., Roivainen M., Lapatto R., Hovi T., Otonkoski T. Mechanisms of coxsackievirus B5 mediated beta-cell death depend on the multiplicity of infection. J Med Virol 2004, 72:586-596.
102. Robinson S.M., Tsueng G., Sin J., Mangale V., Rahawi S., McIntyre L.L., et al. Coxsackievirus B exits the host cell in shed microvesicles displaying autophagosomal markers. PLoS Pathog 2014, 10:e1004045.
103. Le X., Zonghui X., Xiaolin M., Feng H., Hailan Y., Zhewei L. Coxsackievirus B3 induces crosstalk between autophagy and apoptosis to benefit its release after replicating in autophagosomes through a mechanism involving caspase cleavage of autophagy-related proteins. Infect Genet Evol 2014, 26:95-102.
104. Taylor M.P., Burgon T.B., Kirkegaard K., Jackson W.T. Role of microtubules in extracellular release of poliovirus. J Virol 2009, 83:6599-6609.
105. Alexander J.P., Gary H.E., Pallansch M.A. Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J Infect Dis 1997, 175(Suppl. 1):S176-S182.
106. Martin J., Dunn G., Hull R., Patel V., Minor P.D. Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol 2000, 74:3001-3010.
107. Klingel K., Hohenadl C., Canu A., Albrecht M., Seemann M., Mall G., et al. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci USA 1992, 89:314-318.
108. Labadie K., Pelletier I., Saulnier A., Martin J., Colbere-Garapin F. Poliovirus mutants excreted by a chronically infected hypogammaglobulinemic patient establish persistent infections in human intestinal cells. Virology 2004, 318:66-78.
109. Colbere-Garapin F., Christodoulou C., Crainic R., Pelletier I. Persistent poliovirus infection of human neuroblastoma cells. Proc Natl Acad Sci USA 1989, 86:7590-7594.
110. Lloyd R.E., Bovee M. Persistent infection of human erythroblastoid cells by poliovirus. Virology 1993, 194:200-209.
111. Chehadeh W., Kerr-Conte J., Pattou F., Alm G., Lefebvre J., Wattre P., et al. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J Virol 2000, 74:10153-10164.
112. Pelletier I., Duncan G., Colbere-Garapin F. One amino acid change on the capsid surface of poliovirus sabin 1 allows the establishment of persistent infections in HEp-2c cell cultures. Virology 1998, 241:1-13.
113. Pavio N., Couderc T., Girard S., Sgro J.Y., Blondel B., Colbere-Garapin F. Expression of mutated poliovirus receptors in human neuroblastoma cells persistently infected with poliovirus. Virology 2000, 274:331-342.
114. Duncan G., Pelletier I., Colbere-Garapin F. Two amino acid substitutions in the type 3 poliovirus capsid contribute to the establishment of persistent infection in HEp-2c cells by modifying virus-receptor interactions. Virology 1998, 241:14-29.
115. Gosselin A.S., Simonin Y., Guivel-Benhassine F., Rincheval V., Vayssiere J.L., Mignotte B., et al. Poliovirus-induced apoptosis is reduced in cells expressing a mutant CD155 selected during persistent poliovirus infection in neuroblastoma cells. J Virol 2003, 77:790-798.
116. Cooray S. The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival. J Gen Virol 2004, 85:1065-1076.
117. Russell R.C., Tian Y., Yuan H., Park H.W., Chang Y.Y., Kim J., et al. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat Cell Biol 2013, 15:741-750.
118. Jaber N., Dou Z., Chen J.S., Catanzaro J., Jiang Y.P., Ballou L.M., et al. Class III PI3K Vps34 plays an essential role in autophagy and in heart and liver function. Proc Natl Acad Sci USA 2012, 109:2003-2008.
119. Esfandiarei M., Luo H., Yanagawa B., Suarez A., Dabiri D., Zhang J., et al. Protein kinase B/Akt regulates coxsackievirus B3 replication through a mechanism which is not caspase dependent. J Virol 2004, 78:4289-4298.
120. Zhang H.M., Yuan J., Cheung P., Luo H., Yanagawa B., Chau D., et al. Overexpression of interferon-gamma-inducible GTPase inhibits coxsackievirus B3-induced apoptosis through the activation of the phosphatidylinositol 3-kinase/Akt pathway and inhibition of viral replication. J Biol Chem 2003, 278:33011-33019.
121. Yang D., Yu J., Luo Z., Carthy C.M., Wilson J.E., Liu Z., et al. Viral myocarditis: identification of five differentially expressed genes in coxsackievirus B3-infected mouse heart. Circ Res 1999, 84:704-712.
122. Hwang H.Y., Kim J.Y., Lim J.Y., Chung S.K., Nam J.H., Park S.I. Coxsackievirus B3 modulates cell death by downregulating activating transcription factor 3 in HeLa cells. Virus Res 2007, 130:10-17.
123. Pampin M., Simonin Y., Blondel B., Percherancier Y., Chelbi-Alix M.K. Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense. J Virol 2006, 80:8582-8592.
124. Mukherjee A., Morosky S.A., Delorme-Axford E., Dybdahl-Sissoko N., Oberste M.S., Wang T., et al. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog 2011, 7:e1001311.
125. Aldabe R., Irurzun A., Carrasco L. Poliovirus protein 2BC increases cytosolic free calcium concentrations. J Virol 1997, 71:6214-6217.
126. Madan V., Castello A., Carrasco L. Viroporins from RNA viruses induce caspase-dependent apoptosis. Cell Microbiol 2008, 10:437-451.
127. Campanella M., de Jong A.S., Lanke K.W., Melchers W.J., Willems P.H., Pinton P., et al. The coxsackievirus 2B protein suppresses apoptotic host cell responses by manipulating intracellular Ca2+ homeostasis. J Biol Chem 2004, 279:18440-18450.
128. Neznanov N., Kondratova A., Chumakov K.M., Angres B., Zhumabayeva B., Agol V.I., et al. Poliovirus protein 3A inhibits tumor necrosis factor (TNF)-induced apoptosis by eliminating the TNF receptor from the cell surface. J Virol 2001, 75:10409-10420.
129. Neznanov N., Chumakov K.P., Ullrich A., Agol V.I., Gudkov A.V. Unstable receptors disappear from cell surface during poliovirus infection. Med Sci Monit 2002, 8:BR391-BR396.